Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stevioside effervescent tablet suitable for diabetes patients

A technology for diabetics and stevia, applied in the field of natural sweeteners, can solve the problems of bitter aftertaste, small share, sucrose sweetness, incomparable pure mouth, etc., and achieves good effect, high transparency and high finish. Effect

Inactive Publication Date: 2014-07-02
QUFU SHENGXIANGYUAN BIOTECH
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The use of leucylene (L-Citrullol) can improve tablets' properties such as smoother consistencies with liquids or transparent appearance when mixed into drinks like tea or coffee without losing their original taste. This makes it ideal for making liquid food products that contain flavorings.

Problems solved by technology

The technical problem addressed in this patented text relates to improving the flavoring properties of steviose due to its ability to lower down both calory values and stimulating sensitivity while maintaining an appealing taste like white liquors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] 60 times sweeter stevia effervescent tablets

[0021] prescription:

[0022] Stevia (RA content>98%) 20%

[0023] Erythritol 35%

[0024] Tartaric acid 15%

[0025] Sodium bicarbonate 25%

[0026] PvP 2%

[0027] Leucine 3%

[0028] The above raw materials were crushed through a 100-mesh sieve, and acid and alkali were granulated separately. The prescription of acid granules was 1000 grams of stevioside, 1750 grams of erythritol, 1500 grams of tartaric acid, and 100 grams of PVP; the prescription of alkali granules was 1000 grams of stevioside, 1750 grams of erythritol, 2500 grams of sodium bicarbonate, 100 grams of PVP; use 95% ethanol as a binder to make a soft material, granulate with a 16-mesh sieve, dry at 40°C for 2 to 4 hours, turn the granules once per hour, Sieve through a 16-mesh sieve; mix acid and alkali granules, add 300 grams of leucine, mix well and press into tablets to obtain stevioside effervescent tablets with 60 times the sweetness.

[0029] ...

Embodiment 2

[0031] 45 times sweeter effervescent stevia tablets

[0032] prescription:

[0033] Stevia (RA content>98%) 15%

[0034] Erythritol 40 %

[0035] Tartaric acid 15%

[0036] Sodium bicarbonate 25%

[0037] PvP 2%

[0038] Leucine 3%

[0039] The above raw materials were crushed through a 100-mesh sieve, and acid and alkali were granulated separately. The prescription of acid granules was 750 grams of stevioside, 2000 grams of erythritol, 1500 grams of tartaric acid, and 100 grams of PVP; the prescription of alkali granules was 750 grams of stevioside, 2000 grams of erythritol, 2500 grams of sodium bicarbonate, 100 grams of PVP; use 95% ethanol as a binder to make a soft material, granulate with a 16-mesh sieve, dry at 40 ° C for 2 to 4 hours, turn the granules once per hour, Sieve through a 16-mesh sieve; mix acid and alkali granules, add 300 grams of leucine, mix well and press into tablets to obtain stevioside effervescent tablets with 45 times the sweetness.

[0040] ...

Embodiment 3

[0042] 75 times sweeter stevia effervescent tablets

[0043] prescription:

[0044] Stevia (RA content>98%) 25%

[0045] Erythritol 30 %

[0046] Tartaric acid 15%

[0047] Sodium bicarbonate 25%

[0048] PvP 2%

[0049] Leucine 3%

[0050] The above raw materials were crushed through a 100-mesh sieve, and acid and alkali were separately granulated. The prescription of acid granules was 1250 grams of stevioside, 1500 grams of erythritol, 1500 grams of tartaric acid, and 100 grams of PVP; the prescription of alkali granules was 1250 grams of stevioside, 1500 grams of erythritol, 2500 grams of sodium bicarbonate, 100 grams of PVP; use 95% ethanol as a binder to make a soft material, granulate with a 16-mesh sieve, dry at 40°C for 2 to 4 hours, turn the granules once per hour, Sieve through a 16-mesh sieve; mix acid and alkali granules, add 300 grams of leucine, mix well and press into tablets to obtain stevioside effervescent tablets with 75 times the sweetness.

[0051] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a stevioside effervescent tablet suitable for diabetes patients. The stevioside effervescent tablet comprises the following components by weight percent: 15-25 percent of stevioside, 30-40 percent of tetrahydroxy butane, 10-20 percent of tartaric acid, 20-30 percent of sodium bicarbonate, 1-3 percent of PVP and 2-5 percent of leucine. The stevioside effervescent tablet is easily carried and convenient in use, and disintegrates quickly; the taste of stevioside is improved through optimizing the tablet formula based on the complex formulation scheme; and the high-sweetness low-heat effervescent tablet suitable for diabetes patients is provided, and meets the need of people for reduction of diet heat.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Owner QUFU SHENGXIANGYUAN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com